Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin
Robert A. Nagourney et al.
EJSO (2021)
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Francois Quenet et al.
LANCET ONCOLOGY (2021)
The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
Roxan F. C. P. A. Helderman et al.
CELLS (2020)
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
Diane Goere et al.
LANCET ONCOLOGY (2020)
Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study
Judith E. K. R. Hentzen et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
Charlotte E. L. Klaver et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis
Dai Shida et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer
Koji Murono et al.
ANTICANCER RESEARCH (2018)
Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer
Pompiliu Piso et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)
Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia
Camille L. Stewart et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence
Chao-Qun Huang et al.
ONCOTARGET (2017)
Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial
P. H. Cashin et al.
EUROPEAN JOURNAL OF CANCER (2016)
Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis in Norway: Prognostic Factors and Oncologic Outcome in a National Patient Cohort
Ida S. Froysnes et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin
Adrian Cravioto-Villanueva et al.
SURGERY TODAY (2016)
Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy
A. M. Mehta et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Treatment of peritoneal metastases from colorectal cancer
Loreen Maerz et al.
GASTROENTEROLOGY REPORT (2015)
Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis
Wim Ceelen et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: A case-control study from a Chinese center
Chao-Qun Huang et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study
Valery E. Lemmens et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin
Dominique Elias et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Peritoneal carcinomatosis of colorectal origin - Incidence and current treatment strategies
MJ Koppe et al.
ANNALS OF SURGERY (2006)
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study
O Glehen et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
VJ Verwaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
